
CAS 183619-38-7: 4-Acetamido-N-(tert-butyl)benzamide
Description:4-Acetamido-N-(tert-butyl)benzamide is an organic compound characterized by its amide functional group, which is derived from benzoic acid. This compound features a benzene ring substituted with an acetamido group and a tert-butyl group, contributing to its unique properties. The presence of the acetamido group enhances its solubility in polar solvents, while the bulky tert-butyl group can influence its steric hindrance and overall molecular conformation. This compound is typically a white to off-white solid and is used in various chemical applications, including pharmaceuticals and organic synthesis. Its molecular structure allows for potential interactions in biological systems, making it of interest in medicinal chemistry. Additionally, the compound's stability and reactivity can be influenced by the electronic effects of the substituents on the benzene ring. As with many organic compounds, proper handling and safety precautions are essential due to potential toxicity or reactivity.
Formula:C13H18N2O2
InChI:InChI=1/C13H18N2O2/c1-9(16)14-11-7-5-10(6-8-11)12(17)15-13(2,3)4/h5-8H,1-4H3,(H,14,16)(H,15,17)
- Synonyms:
- Ren-1189
- Cpi-1189
- 4-(acetylamino)-N-tert-butylbenzamide
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | CPI-1189 REF: IN-DA00AS51CAS: 183619-38-7 | 98% | To inquire | Thu 27 Mar 25 |
![]() | 4-Acetamido-N-(tert-butyl)benzamide REF: 10-F981175CAS: 183619-38-7 | 97% | 166.00 €~260.00 € | Tue 01 Apr 25 |
![]() | CPI1189 REF: TM-T3561CAS: 183619-38-7 | 98.87% - 99.68% | 35.00 €~820.00 € | Thu 03 Apr 25 |
![]() | CPI-1189 REF: 3D-IHA61938CAS: 183619-38-7 | Min. 95% | - - - | Discontinued product |

CPI-1189
Ref: IN-DA00AS51
1g | 103.00 € | ||
25mg | 28.00 € | ||
100mg | 35.00 € | ||
250mg | 52.00 € |

CPI1189
Ref: TM-T3561
10mg | 46.00 € | ||
25mg | 90.00 € | ||
50mg | 135.00 € | ||
100mg | 215.00 € | ||
200mg | 316.00 € | ||
1mL*10mM (DMSO) | 35.00 € |

CPI-1189
Ref: 3D-IHA61938
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |